Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
J Viral Hepat ; 14(9): 624-32, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17697014

RESUMEN

An estimated 170 million people worldwide have hepatitis C, which is a significant cause of morbidity and mortality. Therefore, health professionals (HPs) are likely to care for people with hepatitis C at some stage in their careers. However, little is known about HPs' attitudes towards treating people with hepatitis C. An analytical, cross-sectional survey was conducted to explore the inter-relationship among HPs' hepatitis C knowledge and attitudes towards treating people with hepatitis C and their self-reported clinical behaviour: Self-administered questionnaires were distributed to 3675 complementary therapists, dentists, medical practitioners, nurses, pharmacists, undergraduate medical and nursing students and people with hepatitis C in Victoria, Australia. Forty-six per cent responded (n = 1510). Only HP (complementary therapists, dentists, medical practitioners, nurses and pharmacists) data is presented (n = 1347). Most HPs demonstrated adequate hepatitis C knowledge, but some displayed intolerant attitudes toward people with hepatitis C. Their self-reported compliance with infection control practices indicated that they frequently treated people with hepatitis C differently from other patients by using additional infection control precautions while treating patients with hepatitis C. In addition, fear of contagion and disapproval of injecting drug use emerged as barriers to their willingness to treat people with hepatitis C. The results suggest that focusing education strategies on changing HPs' attitudes toward people with hepatitis C, injecting drug users, and infection control guidelines rather than concentrating solely on medical information might ultimately improve patient care.


Asunto(s)
Actitud del Personal de Salud , Cuidadores , Hepatitis C , Actitud Frente a la Salud , Australia , Cuidadores/educación , Consejo , Estudios Transversales , Conocimientos, Actitudes y Práctica en Salud , Hepatitis C/transmisión , Humanos , Control de Infecciones , Transmisión de Enfermedad Infecciosa de Paciente a Profesional , Encuestas y Cuestionarios
2.
J Clin Pathol ; 53(3): 206-11, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10823140

RESUMEN

AIMS: To assess A103 (melan-A) immunoreactivity in a range of ovarian sex cord stromal tumours and to evaluate it for the differential diagnosis of other neoplasms. METHODS: Paraffin embedded tissue sections from 45 sex cord stromal tumours and 44 potential histological mimics were examined immunohistochemically using the antibody A103. The sex cord stromal group included 21 adult granulosa cell tumours (AGCT), two juvenile granulosa cell tumours (JGCT), eight tumours showing Sertoli cell or Sertoli-Leydig cell differentiation, two unclassified tumours, two gonadoblastomas, one sex cord tumour with annular tubules, two steroid cell tumours, five thecomas/fibrothecomas, and two sclerosing stromal tumours. The histological mimics include 14 primary ovarian carcinomas, 13 metastatic carcinomas, four carcinoid tumours, four lymphomas, three endometrioid stromal sarcomas, two ovarian tumours of probable Wolffian origin, and one case each of small cell carcinoma, desmoplastic small round cell tumour, melanoma, and primitive neuroectodermal tumour. RESULTS: A103 immunoreactivity was identified in 25 sex cord stromal tumours including 10 AGCT, two JGCT, six Sertoli/Sertoli-Leydig cell tumours, two steroid cell tumours, three thecomas/fibrothecomas, and two sclerosing stromal tumours. Of the potential histological mimics, staining was present only in the two ovarian tumours of probable Wolffian origin and the melanoma. Immunoreactive stromal cells were noted in a minority of cases. Normal hilus cells and rete ovarii epithelium also expressed A103. CONCLUSIONS: A103 is a moderately sensitive and specific marker of sex cord stromal differentiation within the range of tumours examined in this study and as such is a valuable adjunct to other immunocytochemical markers in the assessment of diagnostically problematic ovarian tumours. The staining of normal and neoplastic Wolffian elements merits further investigation.


Asunto(s)
Anticuerpos Antineoplásicos/análisis , Biomarcadores de Tumor/análisis , Melanocitos/inmunología , Neoplasias Ováricas/inmunología , Tumores de los Cordones Sexuales y Estroma de las Gónadas/inmunología , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias Ováricas/diagnóstico , Tumores de los Cordones Sexuales y Estroma de las Gónadas/diagnóstico
3.
J Autism Dev Disord ; 29(3): 191-4, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10425581

RESUMEN

As the treatability of the syndrome of autism becomes more possible there is a great deal more interest in the effectiveness of various therapies. Although the very influential nonmedical literature cited in the Autism Research Review International Newsletter finds that dimethylglycine (DMG) is regarded as more effective than the usual psychopharmacologic drugs, there have been no studies of DMG using the currently accepted research methodology. We report a double-blind, placebo-controlled, crossover pilot study of low dose DMG and placebo in a sample of eight autistic males ranging in age from 4 years 5 months to 30 years 8 months, who completed the full 3 1/2-month study consisting of drug-free baseline periods at the beginning, end, and in-between two, 1-month double-blind trials in which DMG or placebo was given. Measures included the Campbell-NIMH rating scale, an experimental rating scale, and an individualized scale created for each child. Analysis of all three scales revealed no statistically significant differences, and parent reports were equally distributed. The major methodologic weaknesses of the study are thought to be the low dosage of DMG and the small sample size.


Asunto(s)
Trastorno Autístico/tratamiento farmacológico , Sarcosina/análogos & derivados , Adolescente , Adulto , Trastorno Autístico/diagnóstico , Niño , Preescolar , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Humanos , Masculino , Proyectos Piloto , Escalas de Valoración Psiquiátrica , Sarcosina/uso terapéutico , Grabación en Video
5.
Gynecol Oncol ; 64(3): 481-6, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9062155

RESUMEN

Integrin and E-cadherin cell adhesion molecules are important in the maintenance of normal epithelial structures, and altered expression of these molecules may be important in epithelial tumors, particularly in the processes of invasion and metastasis. This study examines the immunohistochemical expression of the alpha2beta1, alpha3beta1, alpha6, and beta4 integrins and of E-cadherin in high-grade cervical intraepithelial neoplasia (CIN) and in invasive carcinoma of the cervix. Abnormal expression of E-cadherin and of all of the integrin subunits examined was detected in the dysplastic epithelium in CIN in the majority of cases, but in a minority of cases this expression was lost in the superficial layers of the dysplastic epithelium. Diffuse expression of E-cadherin and of all of the integrins was seen in the majority of cases of invasive cervical carcinoma. Abnormal expression of integrin cell adhesion molecules occurs in the majority of cases of high-grade CIN, and E-cadherin expression is retained in the dysplastic epithelium. Diffuse expression of integrins and of E-cadherin also occurs in invasive carcinoma, but as the expression pattern was similar in all cases of carcinoma, no correlation with outcome is possible and the significance of this expression is unclear.


Asunto(s)
Cadherinas/biosíntesis , Carcinoma in Situ/metabolismo , Moléculas de Adhesión Celular/biosíntesis , Integrinas/biosíntesis , Neoplasias del Cuello Uterino/metabolismo , Femenino , Humanos , Invasividad Neoplásica , Neoplasias del Cuello Uterino/patología
6.
Histopathology ; 29(3): 217-23, 1996 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8884349

RESUMEN

DNA ploidy, mitotic rate (per 10 high power fields), mitotic index (per 1000 tumour nuclei), Ki-67 labelling index and S phase fraction were measured in 23 uterine leiomyosarcomas and 10 tumours of uncertain malignant potential. Correlations were calculated by Spearmann rank correlation. Univariate survival analysis was performed by log rank analysis and multivariate analysis performed by the Cox linear regression method. Ki-67 index and S phase fraction were significantly higher in leiomyosarcomas than in tumours of uncertain malignant potential. There was significant correlation between mitotic rate, mitotic index, Ki-67 index and S phase fraction in cases of leiomyosarcoma. Fifteen of 22 leiomyosarcomas and one of 10 tumours of uncertain malignant potential were DNA aneuploid. On univariate analysis of all the smooth muscle tumours, DNA ploidy, presence of significant nuclear atypia and presence of coagulative tumour cell necrosis were associated with outcome. Only DNA ploidy was associated with outcome in the group of leiomyosarcomas. On multivariate analysis of all of the smooth muscle tumours, DNA ploidy, age and grade of atypia were independently associated with outcome. No single factor was independently predictive of outcome in the group of leiomyosarcomas. Alternative indices of cell proliferation correlate with mitotic rate in uterine leiomyosarcoma and do not provide additional useful prognostic information. DNA ploidy, age and grade of atypia are independently associated with outcome in uterine smooth muscle tumours and measurement of DNA ploidy may be useful in identification of cases with an adverse prognosis.


Asunto(s)
Neoplasias de Tejido Muscular/genética , Neoplasias de Tejido Muscular/patología , Neoplasias Uterinas/genética , Neoplasias Uterinas/patología , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Femenino , Humanos , Inmunohistoquímica , Antígeno Ki-67/análisis , Leiomiosarcoma , Modelos Lineales , Persona de Mediana Edad , Índice Mitótico , Músculo Liso/patología , Neoplasias de Tejido Muscular/inmunología , Ploidias , Fase S , Análisis de Supervivencia , Neoplasias Uterinas/inmunología
7.
Int J Gynecol Pathol ; 15(1): 34-8, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8852444

RESUMEN

Persistent gestational trophoblastic disease (PGTD) is a significant complication of complete hydatidiform mole. There are, however, no reliable clinical or pathological parameters to predict the development of PGTD following the evacuation of a complete mole. In this study we examined the value of Ki67 expression in the prediction of PGTD following complete mole. Immunohistochemistry for Ki67 was performed on 21 cases of complete mole complicated by PGTD and 17 cases that resolved spontaneously after evacuation. Strong Ki67 expression was seen in both villous cytotrophoblast and extravillous trophoblast of the complete moles. The Ki67 index of extravillous trophoblast was significantly higher than that of villous cytotrophoblast. There was no significant difference in Ki67 index of either villous cytotrophoblast or extravillous trophoblast between cases of complete mole complicated by PGTD and those that resolved spontaneously. Trophoblast proliferation rate does not predict outcome following complete hydatidiform mole. Other factors involved in myometrial invasion may be of importance in the development of this complication, but serum chorionic gonadotrophin level is the only reliable predictor of the development of persistent gestational trophoblastic disease.


Asunto(s)
División Celular , Progresión de la Enfermedad , Mola Hidatiforme/patología , Neoplasias Trofoblásticas/patología , Trofoblastos/patología , Biomarcadores , Vellosidades Coriónicas/patología , Femenino , Humanos , Mola Hidatiforme/complicaciones , Inmunohistoquímica , Antígeno Ki-67/biosíntesis , Embarazo
8.
J Pathol ; 177(1): 65-70, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7472782

RESUMEN

Mutation and overexpression of p53 have been described in uterine malignant mixed Müllerian tumours and in endometrial adenocarcinoma, where it has been associated with a poor prognosis. This study examines p53 expression and mutation of the p53 gene in benign and malignant smooth muscle tumours of the uterine corpus. p53 expression was evaluated by immunohistochemistry in formalin-fixed, paraffin-embedded tissue from 23 leiomyosarcomas, 10 tumours of uncertain malignant potential (TUMPs), and 18 leiomyomas. Single-stranded conformational polymorphism, (SSCP) analysis of exons 5-8 of the p53 gene was performed on 13 leiomyosarcomas, nine TUMPs, and eight leiomyomas. With microwave antigen retrieval, p53 immunoreactivity was seen in 13/23 microwave treatment, staining was abolished in three leiomyosarcomas, all immunoreactive TUMPs, and the single positive leiomyoma. SSCP analysis revealed mutation in three leiomyosarcomas. There was one mutation in exon 5 in a case with positive immunohistochemistry. Two cases with negative staining showed mutation, one in exon 7 and one in exon 8. Mutation was present in exon 7 in 4/9 and in exon 6 in 1/9 TUMPs. All of these cases showed positive immunohistochemistry. There was no significant difference in outcome between cases with and without positive immunohistochemistry. p53 expression is seen in a significant proportion of uterine leiomyosarcomas. Microwave antigen retrieval increases the proportion of positive cases and also results in positive staining in TUMPs. Mutation of the p53 gene occurs in only a minority of leiomyosarcomas and in a significant proportion of TUMPs. Positive immunohistochemistry does not, however, correlate with the presence of mutation and other factors may be responsible for p53 detection in many cases.


Asunto(s)
Genes p53 , Leiomiosarcoma/genética , Mutación , Proteína p53 Supresora de Tumor/metabolismo , Neoplasias Uterinas/genética , Secuencia de Bases , Femenino , Expresión Génica , Humanos , Técnicas para Inmunoenzimas , Leiomiosarcoma/metabolismo , Leiomiosarcoma/mortalidad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Polimorfismo Conformacional Retorcido-Simple , Tasa de Supervivencia , Neoplasias Uterinas/metabolismo , Neoplasias Uterinas/mortalidad
9.
Mod Pathol ; 8(7): 701-4, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8539225

RESUMEN

Overexpression of the c-myc proto-oncogene occurs in carcinoma of the ovary, endometrium, and cervix, and is associated with an adverse prognosis, but little is known about the pattern of c-myc expression in uterine sarcomas. This study investigates the expression of c-myc in uterine smooth muscle tumors and malignant mixed müllerian tumors. Twenty-three leiomyosarcomas, 10 leiomyomas, and 9 malignant mixed müllerian tumors were examined for c-myc overexpression by immunohistochemistry. Differences in mitotic rate and in survival were compared in c-myc positive and negative cases of leiomyosarcoma. Overexpression of c-myc was seen in 6/12 leiomyomas, 11/23 leiomyosarcomas, and 9/9 malignant mixed müllerian tumors. Positive staining was restricted to a perinuclear location in all of the leiomyomas and one leiomyosarcoma. Diffuse cytoplasmic staining was seen in the remaining 10 positive leiomyosarcomas. Positive staining was seen in both epithelial and stromal elements of malignant mixed müllerian tumors, including homologous and heterologous areas of stromal differentiation. There was no significant difference in mitotic rate or in survival between c-myc positive and negative cases of leiomyosarcoma. Overexpression of c-myc occurs in many uterine leiomyosarcomas and the majority of malignant mixed müllerian tumors. Overexpression of c-myc also occurs in benign uterine smooth muscle tumors but with a different pattern than that seen in malignant tumors. This overexpression does not correlate with survival and the significance of overexpression of c-myc in these tumors is unclear.


Asunto(s)
Genes myc , Leiomioma/genética , Leiomiosarcoma/genética , Tumor Mulleriano Mixto/genética , Neoplasias Uterinas/genética , Núcleo Celular/química , Citoplasma/química , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Leiomioma/química , Leiomioma/patología , Leiomiosarcoma/química , Leiomiosarcoma/patología , Tumor Mulleriano Mixto/química , Tumor Mulleriano Mixto/patología , Pronóstico , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas c-myc/análisis , Tasa de Supervivencia , Neoplasias Uterinas/química , Neoplasias Uterinas/patología
10.
Int J Gynecol Pathol ; 11(4): 266-72, 1992 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1399232

RESUMEN

Increased expression of epidermal growth factor (EGF) receptor has been recorded in many types of human tumors and has been associated with reduced survival in ovarian carcinoma. The purpose of this study was to examine the immunocytochemical distribution of the EGF receptor in normal ovaries (n = 30) and in ovarian tumors (n = 126). Staining was observed in two normal ovaries, in the granulosa cells of a developing follicle, and in surface epithelium. Forty-seven of 103 malignant common epithelial tumors were immunopositive. Staining was usually focal, always confined to the neoplastic epithelium, and showed a cytoplasmic distribution. There was a slight trend for increased EGF receptor expression in more advanced common epithelial malignancies, but this was not statistically significant. No correlation between immunoreactivity and histological subtype or grade of tumor was seen. A few other tumors were also examined: one each of Brenner tumor, mature teratoma, mature teratoma with squamous carcinoma, borderline serous tumor and fibroma; all were immunopositive.


Asunto(s)
Carcinoma/química , Receptores ErbB/análisis , Neoplasias Ováricas/química , Ovario/química , Carcinoma/patología , Femenino , Humanos , Inmunohistoquímica , Estadificación de Neoplasias , Neoplasias Ováricas/patología
11.
Artículo en Inglés | MEDLINE | ID: mdl-2335692
16.
Diabetologia ; 29(5): 267-74, 1986 May.
Artículo en Inglés | MEDLINE | ID: mdl-3522324

RESUMEN

A 25-year computerised survey of deaths in the United Kingdom among diabetic patients of 19 years of age and under was performed. Suitable pancreatic material was available in 119 out of the 498 identified patients. The duration of diabetes was known in 95 of the 119 patients. In 60 patients it had been present for less than 1 year. Insulitis was present in 47 of the 60 patients (78%) with recent onset disease, and was also found in 3 patients who had been treated for diabetes for between 1 and 6 years. In cases in which it was identified, insulitis affected 23% of islets containing insulin, but affected only 1% of islets which were insulin deficient, thus supporting the concept that insulitis represents an immunologically mediated destruction of insulin secreting B cells. Four patients appeared to have a different disease from classical Type 1 (insulin-dependent) diabetes in that there was no evidence of insulitis and all islets contained insulin. The age of onset of diabetes was eighteen months or less in these patients.


Asunto(s)
Diabetes Mellitus Tipo 1/patología , Islotes Pancreáticos/patología , Adolescente , Adulto , Niño , Preescolar , Diabetes Mellitus Tipo 1/mortalidad , Femenino , Humanos , Lactante , Masculino , Factores de Tiempo , Reino Unido
18.
J Med Genet ; 22(2): 112-8, 1985 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3989824

RESUMEN

Asphyxiating thoracic dystrophy is an autosomal recessive disorder characterised by an abnormally small thorax, variable shortening of the extremities, and pelvic anomalies. Renal and pancreatic symptoms are found in longer survivors, although most cases die in infancy of respiratory failure. Seven neonatal cases were studied at necropsy. These cases ranged in gestational age from 32 to 40 weeks. One was stillborn and the other six survived from 1 hour to 10 days. Two were sibs born to consanguineous parents. Dwarfing was not pronounced and the extremities were shortened in only one infant who also had polydactyly. All seven showed visceral changes in addition to abnormalities of bone. Endochondral ossification was irregular in sections of femur, vertebra, and rib. Pulmonary hypoplasia was associated with the small thorax typical of this disorder. Periportal fibrosis and bile duct proliferation were seen in sections of liver, and in one case cirrhosis was found. Pancreatic fibrosis was variable. These necropsy findings correlate with later clinical manifestations of the disease and emphasise the multisystem nature of this disorder.


Asunto(s)
Asfixia Neonatal/patología , Enanismo/patología , Genes Recesivos , Tórax/anomalías , Asfixia Neonatal/genética , Huesos/patología , Consanguinidad , Enanismo/genética , Femenino , Humanos , Recién Nacido , Riñón/patología , Hígado/patología , Pulmón/patología , Masculino , Páncreas/patología , Linaje , Síndrome
20.
Theor Appl Genet ; 63(1): 1-7, 1982 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24270693

RESUMEN

Variation at polymorphic isozyme loci was analyzed in Nantucket pine tip moth (NPTM) populations from 5 geographic locations. At the North Carolina location, populations representing 3 generations at 3 local sites were also studied. Four of the loci investigated (LAP, MDH, α-GPDH and AK), although variable, had few alleles per locus (3-5) and few differences among populations in allele frequencies. At each locus, all populations had the same allele at a high frequency.At the PGM locus, fifteen alleles were identified and allelic frequencies varied among populations. At least eight alleles were present within a population and, in most populations, two or more alleles had high frequencies that differed among populations. An excess of homozygotes over Hardy-Weinberg expectations was found for 7 out of the 10 populations studied, indicating the probable existence of some form of inbreeding structure or populational subdivision within sampled stands.Joint consideration of the results observed for PGM and the other four loci is counterindicative of neutrality at all loci and strongly indicative of genetic differentiation among locally disjunct populations.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA